Differences in activities of thromboxane A2 receptor antagonists in smooth muscle cells
- 1 October 1992
- journal article
- Published by Elsevier in European Journal of Pharmacology: Molecular Pharmacology
- Vol. 227 (2) , 199-204
- https://doi.org/10.1016/0922-4106(92)90128-i
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Cloning and expression of cDNA for a human thromboxane A2 receptorNature, 1991
- Receptor profile of KW-3635: a potent, selective and orally active thromboxane A2 receptor agonistEuropean Journal of Pharmacology, 1990
- Protective effects of KW-3635, a novel thromboxane A2 antagonist, in murine traumatic shockEuropean Journal of Pharmacology, 1990
- Actions of second messengers synthesized by various spasmogenic agents and their relation to mechanical responses in dog tracheal smooth muscleBritish Journal of Pharmacology, 1990
- Distinct platelet thromboxane A2/prostaglandin H2 receptor subtypes. A radioligand binding study of human platelets.Journal of Clinical Investigation, 1989
- Biochemical characterization and comparison of rat thromboxane A2/prostaglandin H2 receptors in platelets and cultured aortic smooth muscle cellsBiochemical Pharmacology, 1989
- Thromboxane A2 activates phospholipase C in astrocytoma cells via pertussis toxin-insensitive G-proteinEuropean Journal of Pharmacology, 1989
- Thromboxane A2: Its generation and role in platelet activationProgress in Lipid Research, 1989
- Effects of prostaglandins on the cytosolic free calcium concentration in vascular smooth muscle cellsBiochemical and Biophysical Research Communications, 1986
- Analysis of radioligand binding experimentsJournal of Pharmacological Methods, 1985